Hashimoto's thyroiditis pathology and risk for thyroid cancer

Thyroid

Volumn 24, Issue 7, 2014, Pages 1107-1114

  Paparodis, Rodis ^a   Imam, Shahnawaz ^a   Todorova Koteva, Kristina ^a   Staii, Anca ^a   Jaume, Juan Carlos ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; IODIDE PEROXIDASE;

ADULT; ANTIBODY TITER; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; DISEASE DURATION; DRUG MEGADOSE; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION; THYROID PARAFOLLICULAR CELL; THYROID SURGERY; BLOOD; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; RISK; THYROID GLAND; THYROID NEOPLASMS;

ADULT; FEMALE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; MALE; MIDDLE AGED; RISK; THYROID GLAND; THYROID NEOPLASMS; THYROTROPIN; THYROXINE;

EID: 84903618089     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0588     Document Type: Article

References (28)

1. Li N, Du XL, Reitzel LR, Xu L, Sturgis EM 2013 Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: Review of incidence trends by socioeconomic status within the Surveillance, Epidemiology, and End Results registry, 1980-2008. Thyroid 23: 103-110
2. Chen H, Schneider D, Mazeh H, Jaume JC, Lubner S 2013 Endocrine Cancer. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds) Abeloff's Clinical Oncology, 5th edition. Churchill Livingstone Elsevier, Philadelphia, PA, pp. 1112-1142
3. Braverman LE 1994 Iodine and the thyroid: 33 years of study. Thyroid 4:351-356
4. Virchow R 1956 Standpoints in Scientific Medicine, 1877. Bull Hist Med 30:537-543
5. Balkwill F, Mantovani A 2001 Inflammation and cancer: Back to Virchow?. Lancet 357:539-545
6. Franks AL, Slansky JE 2012 Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res 32:1119-1136
7. Dailey ME, Lindsay S, Skahen R 1955 Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 70:291-297
8. Holm LE, Blomgren H, Lowhagen T 1985 Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312:601-604
9. Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA 2005 Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 71:874-878
10. Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA 2013 Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting hashimotos thyroiditis. J Clin Endocrinol Metab 98:2409-2414
11. Eisenberg BL, Hensley SD 1989 Thyroid cancer with coexistent Hashimoto's thyroiditis. Clinical assessment and management. Arch Surg 124:1045-1047
12. Fiore E, Rago T, Latrofa F, ProvenzaleMA, Piaggi P,Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P 2011 Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: Role of TSH and of treatment with L-Thyroxine. Endocr Relat Cancer 18:429-437
13. Fiore E, Rago T, Scutari M, Ugolini C, Proietti A, Di Coscio G, Provenzale MA, Berti P, Grasso L, Mariotti S, Pinchera A, Vitti P 2009 Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-Antibodies in patients with nodular thyroid diseases. J Endocrinol Invest 32:344-351
14. Jankovic B, Le KT, Hershman JM 2013 Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: Is there a correlation?. J Clin Endocrinol Metab 98:474-482
15. Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, Evers BM 2007 Increased incidence of welldifferentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 204:764-773
16. Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E 1987 The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 53:442-445
17. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H 2008 Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?. J Surg Res 150:49-52
18. Zhang L, Li H, Ji QH, Zhu YX, Wang ZY, Wang Y, Huang CP, Shen Q, Li DS, Wu Y 2012 The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease. BMC Cancer 12:610
19. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR 1995 Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma.Astudy of surgical cases among Japanese, and white and African Americans. Cancer 76:2312-2318
20. Rago T, Di Coscio G, Ugolini C, Scutari M, Basolo F, Latrofa F, Romani R, Berti P, Grasso L, Braverman LE, Pinchera A, Vitti P 2007 Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol 67:363-369
21. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H 2009 Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol 71:434-439
22. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metabl 93:809-814
23. Song Y, Driessens N, Costa M, De Deken X, Detours V, Corvilain B, Maenhaut C, Miot F, Van Sande J, Many MC, Dumont JE 2007 Roles of hydrogen peroxide in thyroid physiology and disease. J Clin Endocrinol Metab 92:3764-3773
24. BorrelloMG,Alberti L, FischerA,Degl'innocentiD, Ferrario C, Gariboldi M, Marchesi F, Allavena P, Greco A, Collini P, Pilotti S, Cassinelli G, Bressan P, Fugazzola L,Mantovani A, Pierotti MA 2005 Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad Sci USA 102:14825-14830
25. Nose F, Ichikawa T, Fujiwara M, Okayasu I 2002 Upregulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: Significant correlation with inducible nitric oxide synthase. Am J Clin Pathol 117:546-551
26. Schreiber RD, Old LJ, Smyth MJ 2011 Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 331:1565-1570
27. Imam S, Paparodis R, Sharma D, Jaume JC 2014 Lynphocytic profiling in thyroid cancer provides clues for failure of tumor immunity. Endocr Relat Cancer 21: 505-516
28. Kaufman HL, Wolchok JD 2006 Is tumor immunity the same thing as autoimmunity?. Implications for cancer immunotherapy. J Clin Oncol 24:2230-2232